Skip to search.
 All Ordinaries Up 0.33%

More On VLA.AX

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Viralytics Ltd (VLA.AX)

-ASX
0.95 Up 0.07(7.95%) 27 May 16:10
Prev Close:0.88
Open:0.91
Bid:0.95
Ask:0.96
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:0.91 - 0.96
52wk Range:0.52 - 0.96
Volume:563,468
Avg Vol (3m):195,213
Market Cap:225.43M
P/E (ttm):N/A
EPS (ttm):-0.04
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in AUD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):69.86
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-14) :N/A
Quarterly EPS Est (Dec-14) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Viralytics Limited, a biotechnology company, engages in developing oncolytic immunotherapy treatments for a range of cancers in Australia. Its lead investigational product is CAVATAK, a proprietary formulation of the common cold Coxsackievirus Typ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback